Review Article Dermatology Geriatrics
Vitamin D supplementation and glycaemic control in patients with hip fracture: A quality-improvement audit

Vitamin D supplementation and glycaemic control in patients with hip fracture: A quality-improvement audit

Authors

Aisha Nakamura

Aisha Nakamura

Cleveland Clinic Abu Dhabi, Palau

Corresponding
James Rahman

James Rahman

Royal Melbourne Hospital, Fiji Islands

Leo Rossi

Leo Rossi

Toronto General Hospital, Nauru

Ethan Volkov

Ethan Volkov

Royal Melbourne Hospital, Bulgaria

Published

February 9, 2025

Paper ID

PAP-000123

Status

Published

DOI

10.65712/tmj.test000381

Vitamin D supplementation and glycaemic control in patients with hip fracture: A quality-improvement audit

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of glycaemic control to health systems is substantial. Methods: Eligible participants were patients with hip fracture. Results: Serious adverse events were rare and similar between groups. 999 participants were included (median age 68 years). Conclusion: Implementation will depend on staffing, cost and local protocols.

Introduction

Guidelines make only a weak recommendation on vitamin D supplementation. The cost of glycaemic control to health systems is substantial.

Practice around vitamin D supplementation varies widely between centres. glycaemic control remains a leading cause of avoidable harm among patients with hip fracture. Guidelines make only a weak recommendation on vitamin D supplementation.

Materials and Methods

The primary outcome was glycaemic control, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.

Eligible participants were patients with hip fracture. The primary outcome was glycaemic control, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.

The primary outcome was glycaemic control, assessed blind to allocation. Missing data were handled with multiple imputation.

Eligible participants were patients with hip fracture. Analyses were adjusted for age, sex and baseline severity. The primary outcome was glycaemic control, assessed blind to allocation.

Results

glycaemic control occurred in 11% of the intervention group versus 23% of controls. Serious adverse events were rare and similar between groups. 4066 participants were included (median age 74 years). glycaemic control occurred in 16% of the intervention group versus 31% of controls.

GroupnEvents
Centre B41747
Centre A32672
Centre B27837
Centre B11222
Centre B82926
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in glycaemic control
Shown for patients with hip fracture; error bars are 95% confidence intervals.

Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.38 (95% CI 0.46 to 0.98). The adjusted odds ratio was 0.75 (95% CI 0.39 to 0.93). glycaemic control occurred in 6% of the intervention group versus 38% of controls.

Discussion

Future work should test vitamin D supplementation in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. These findings suggest that vitamin D supplementation is associated with better glycaemic control in patients with hip fracture.

Implementation will depend on staffing, cost and local protocols.

Implementation will depend on staffing, cost and local protocols. These findings suggest that vitamin D supplementation is associated with better glycaemic control in patients with hip fracture.

Future work should test vitamin D supplementation in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.

Future work should test vitamin D supplementation in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.

Conclusions

Vitamin D supplementation should be considered for patients with hip fracture to improve glycaemic control.

References

1. Mensah I, Novak L, et al. An antibiotic stewardship programme and acute kidney injury. Ann Intern Med. 2013;92(4):441-1738.

2. Osei N, Yilmaz V, et al. Tranexamic acid and health-related quality of life. Eur Heart J. 2022;75(6):358-1686.

3. Rahman G, Mensah G, et al. SGLT2 inhibitors and 30-day readmission. JAMA. 2023;191(2):531-1366.

4. Rossi N, Andersen S, et al. Low-dose aspirin and 30-day readmission. JAMA. 2017;355(4):609-949.

5. Yilmaz K, Moreau T, et al. Nurse-led discharge planning and patient satisfaction. BMC Med. 2019;213(12):697-1617.

6. Mueller U, Mensah H, et al. Early enteral nutrition and falls. JAMA. 2014;62(8):389-1082.

7. Patel Y, Mueller R, et al. Machine-learning triage and emergency department revisits. Lancet. 2023;386(4):868-1069.

8. Okafor U, Zhang P, et al. High-flow nasal oxygen and medication adherence. JAMA. 2021;216(12):266-939.

Appendices

Supplementary tables are available on request.